A number of London-based doctors claim to have effectively cured two babies of leukaemia, following a world-first attempt to treat the condition using genetically engineered immune cells from a donor. The Great Ormond Street Hospital in the UK’s capital provided the facilities and support for the medical trial and now introduce hope for an off-the-shelf approach to cancer treatment. Instead of the expensive and physically intense chemo-therapy system, experts are now suggesting that donated cells could be genetically engineered and intravenously introduced into patients in a shorter amount of time.
Unlike the approach of other medical visionaries, which concentrate on collecting and re-engineering patient cells, this therapeutic system allows for more efficient turnaround times and at potentially reduced costs. Instead of using only T-cells, the new system allows for universal cells to be created, that can adapt once inside the patient’s bloodstream.
As indicated in Science Translational Medicine, the British infants, aged 11 and 16 months, had both been previously diagnosed with leukaemia and provided treatment which failed. Leading Physicial & Gene Therapy Expert, Waseem Qasim, confirms that both children remain in remission, to date.